Linezolid for the treatment of resistant grampositive. Enterococcus is a significant pathogen in numerous infections, particularly in nosocomial infections, and is thus a great challenge to clinicians. Vancomycinresistant enterococcus treatment guidance. Pdf novel linezolid resistance plasmids in enterococcus. A relatively high rate of vancomycinresistant enterococcus faecium not susceptible to linezolid was observed in intensive care unit patients. Update on prevalence and mechanisms of resistance to linezolid.
We describe a large hospital outbreak of lre infections. The responses to different daptomycin doses have not been studied. Detection of the novel optra gene among linezolidresistant. Vancomycin resistant enterococcus faecium meningitis successfully managed with linezolid.
Linezolid resistance has emerged in enterococci during antimicrobial therapy and as a result of crossinfection. Vancomycinresistant enterococcal bacteremia vreb is a common nosocomial infection associated with significant morbidity and mortality. The significance is that vana vre is resistant to both vancomycin and teicoplanin, vanb vre is resistant to vancomycin but susceptible to teicoplanin, and vanc is only partly resistant to vancomycin. Daptomycin versus linezolid for treatment of vancomycin.
Validating a screening agar for linezolid resistant enterococci guido werner, carola fleige, ingo klare, robert e. Due to high rates of resistance and a limited number of efficacious antimicrobials for vancomycin. Here, we report infections due to linezolid and vancomycin resistant enterococcus lrvre strains in patients who were treated with linezolid in a tertiarycare hospital in brazil. Research response to emerging infection leading to. There are at least 18 different species of these bacteria. Emergence of optramediated linezolid resistance in. Meanwhile, daptomycin exerts bactericidal activity against vre, but is not approved for the treatment of vre bacteremia. The purpose of this study was to assess clinical and microbiologic outcomes associated with the use of linezolid or daptomycin in the treatment of vre. Indeed, the number of infections with vancomycin resistant enterococci vre in us hospitals increased from 9,820 in 2000 to 21,352 in 2006 ref. Two linezolid vancomycin resistant enterococci were e. Linezolid is an antibiotic with activity against vre that is available orally, but only 30% of each dose is excreted in the urine. The first linezolidresistant enterococcus faecium in india.
Linezolid for treatment of vancomycin resistant enterococcal peritonitis elaine m. Infections due to vancomycinresistant enterococcus faecium. Here, we report infections due to linezolid and vancomycin resistant enterococcus lrvre strains in patients who were treated with linezolid in a. Emergence of linezolid resistance in the vancomycin. Research response to emerging infection leading to outbreak. We performed a casecontrol study during a hospital outbreak of linezolid resistant enterococci lre infections, comparing cases of lre infection cases with linezolid sensitive enterococci infections controls. Linezolid is an antibiotic used for the treatment of infections caused by grampositive bacteria that are resistant to other antibiotics.
Survival of patients with vancomycinresistant enterococcus. Linezolid and phenicol resistance optra in enterococcus. The emerging problem of linezolidresistant enterococci. Enterococcus faecium and enterococcus faecalis, the nosocomial pathogens 5 table 3. The purpose of this study was to describe the presence of the novel optra gene among clinical isolates of enterococci in a spanish teaching hospital may 2016april 2017. Zyvox linezolid injection linezolid tablets linezolid for oral suspension to reduce the development of drugresistant bacteria and maintain the effectiveness of zyvox formulations and other antibacterial drugs, zyvox should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Since the introduction of the oxazolidinone linezolid in 2000, widespread use has led to reports of linezolid resistant vre as well as nosocomial transmission of linezolidresistant vre in hospitals. Linezolid resistance is on the rareunusual resistance list and we should follow up on resistance mechanisms origin of the resistant strains or plasmids. While treatment options for vre bacteremia are limited, linezolid is currently fdaapproved for vre infection. Linezolidresistant enterococcus faecalis isolated from a. Vancomycin resistant enterococcal bacteremia vre b is a common nosocomial infection associated with significant morbidity and mortality.
A 42yearold woman on continuous ambulatory peritoneal dialysis capd developed peritonitis secondary to vancomycin resistant enterococcus faecium and candida albicans while hospitalized for pneumonia. Linezolid lzd has become one of the most important antimicrobial agents for infections caused by grampositive bacteria, including those caused by enterococcus species. Epidemiologic investigation and pulsedfield gel electrophoresis patterns indicated a clonal outbreak related to nosocomial. Vancomycin resistant enterococci vre has emerged as an important pathogen causing nosocomial infections and vancomycin resistance has been shown to be a principal predictor of mortality with regard to enterococcal bacteremia. Because of the important niche of linezolid in cancer treatment, linezolid resistant e. Nasal and perirectal swab samples were obtained from all patients in a 1day pointprevalence survey. Linezolid is an alternative treatment option for infections with multidrug resistant grampositive bacteria including vancomycin resistant enterococci vre. Linezolid was approved in 2000 for treatment of grampositive coccal infections. The purpose of this study was to assess clinical and microbiologic outcomes associated with the use of linezolid or daptomycin in the treatment of vre bacteremia. Linezolid is the first oral antimicrobial agent approved for the treatment of vancomycin resistant enterococci. The first linezolidresistant enterococcus faecium in. We report a linezolid resistant enterococcus faecalis infection in a cord blood stem cell transplant recipient previously treated with linezolid for bloodstream infections by vancomycin resistant enterococci. Nafziger, md c a 42yearold woman on continuous ambulatory peritoneal dialysis capd developed peritonitis secondary to vancomycin resistantenterococcus faecium and candida albicans while hospitalized for pneumonia.
Determination of risk factors associated with isolation of linezolid resistant strains of vancomycin resistant enterococcus. Gene dosage and linezolid resistance in enterococcus faecium. Vancomycin resistant enterococci are important pathogens for healthcareassociated infections. The emerging problem of linezolidresistant enterococcus. Enterococcus faecium and enterococcus faecalis the nosocomial. To investigate linezolid resistance mechanisms in linezolid nonsusceptible enterococci lnse isolated from a tertiary hospital in korea.
Vancomycinresistant enterococci vre are important nosocomial pathogens. However, the emergence of resistance during linezolid treatment has been reported for clinical strains of enterococcus. Linezolid is active against most grampositive bacteria that cause disease, including streptococci, vancomycin resistant enterococci vre, and methicillin resistant staphylococcus aureus mrsa. Linezolidresistant enterococci oxford academic journals. Although the outbreak was contained, linezolid resistant enterococci emerged during and after the outbreak as the usage of linezolid became more common. Linezolid is an important agent in the treatment of serious infections caused by multidrug resistant grampositive organisms, including methicillin resistant s. Sequencing showed a g2576u mutation in the 23s rrna gene. In april 2000, linezolid was approved in the united states and has been heavily marketed to treat methicillinresistant staphylococcus aureus mrsa and vancomycinresistant enterococci. This is the first report from pakistan where linezolid and vancomycin resistant enterococcus faecium was isolated from cerebrospinal fluid csf. Pdf increasing incidence of linezolidintermediate or. Vancomycin resistant enterococci abstract treatment options for vancomycin resistant enterococci vre bloodstream infection are limited.
Some countries report an increasing number of isolates with resistance to linezolid. Complete genome sequence and characterization of linezolid. She was treated successfully with intravenous linezolid, fluconazole given by nasogastric tube, and removal of the peritoneal catheter. Since the oxazolidinones have a unique mechanism of action and expanded spectrum of activity against virulent and highly resistant grampositive pathogens, linezolid is a valuable alternative to currently available treatment options. Hospital outbreak caused by linezolid resistant enterococcus. Pdf linezolid provides high rates of the clinical cure and microbiological success in complicated infections due to enterococcus spp. Linezolid resistance in vancomycinresistant enterococci vre strains has been rarely reported, with enterococcus faecium being the species most commonly. Daptomycin and linezolid are primary treatment options although definitive clinical data to assess comparative therapeutic effectiveness are lacking. Each patient was treated with linezolid for vre infection.
Only a few studies with small sample sizes have compared the effectiveness of these drugs for treatment of vre bacteremia. Emergence of linezolid resistance in hepatobiliary infections. During 2004 and at the start of 2005 a university hospital in southwest germany was affected by an extensive outbreak of vancomycin resistant enterococcus faecium vre. Request pdf the emerging problem of linezolidresistant enterococcus enterococcus is a significant pathogen of numerous infections, particularly. Cureus a case report on isolation of linezolid and. Linezolid resistance in vancomycin resistant enterococci vre strains has been rarely reported, with enterococcus faecium being the species most commonly associated with these few cases 1, 2, 3. In march 2014, an outbreak of linezolid resistant enterococcus faecium lrefm was observed at the.
Colonisation with vancomycin and linezolid resistant enterococcus faecium in a university hospital. Linezolid in the treatment of vancomycinresistant enterococcus faecium in solid organ transplant recipients. Emergence of linezolid resistance in hepatobiliary infections caused. Emergence of linezolid and vancomycinresistant enterococcus. We report clinical details and antibiotic susceptibility from five patients treated with linezolid for vre infections who had resistant organisms isolated during therapy. Jul 21, 2001 the new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various grampositive bacteria, including meticillin resistant staphylococcus aureus mrsa and vancomycin resistant enterococci vre. Pdf the first linezolidresistant enterococcus faecium in india. Enterococci are a type of bacteria that live in your gi tract.
The most recently approved drug with good activity against enterococci is linezolid. Failure of linezolid treatment for enterococcal endocarditis. Request pdf enterococcus faecalis resistant to linezolid. In may 2004 our institution encountered its first clinical isolate of linezolid resistant, vancomycin resistant enterococcus faecium lrvre. Linezolid resistance in a clinical isolate of staphylococcus. Linezolidresistant isolates carried the g2576t mutation in the 23s rrna gene, belonged to different clones, and shared the same allelic profile, which clusters in the c1 multilocus sequence typing epidemic lineage. Jan 16, 2012 reports of linezolid resistance among enterococcus faecalis have been relatively rare. Linezolid is the only agent with an fdaapproved indication for vre infections, including bacteremia. Comparison of linezolid and daptomycin for the treatment. Among them, the optra gene was detected in five enterococcus faecalis isolated from unrelated patients. Most reports of linezolidresistant enterococci lre have been individual cases or small case series 1020 or have speci.
Based on largescale clinical studies, the oral and injection dosage forms of linezolid are equally effective in the treatment of mrsa, and are also effective against infections such as vancomycin. However, the emergence of resistance during linezolid treatment has been reported for clinical strains of enterococcus, which is alarming given the fact that, this leaves the clinician with very few treatment options. Linezolid is a synthetic antibiotic in a new class of antimicrobials called the oxazolidinones. Vancomycin resistant enterococcal bacteremia vreb is a common nosocomial infection associated with significant morbidity and mortality. Linezolid resistance in vancomycinresistant enterococcus. Studies comparing daptomycin or linezolid in treating vre bloodstream infection have con. Linezolid resistant enterococcus faecium and enterococcus faecalis isolated from a septic patient.
Currently, the prevalence of methicillin resistant staphylococci mrsa and vancomycin resistant enterococci vre is a major clinical problem. Daptomycin and linezolid are primary treatment options alt. Over time there have been reports where linezolid resistance in enterococci has been documented. Linezolid provides high rates of clinical cure and microbiological success in complicated infections due to enterococcus spp. Here, we report the cluster of linezolid and vancomycin resistant enterococcus faecium lvre in a german department for hematologic stem cell transplantation hsct. The main uses are infections of the skin and pneumonia. Data on the efficacy of linezolid in the treatment of uti is limited. Linezolidresistant enterococcus faecium and enterococcus. Linezolid for treatment of urinary tract infections. Linezolid in the treatment of vancomycin resistant enterococcus faecium in solid organ transplant recipients. A 42yearold woman on continuous ambulatory peritoneal dialysis capd developed peritonitis secondary to vancomycinresistant enterococcus faecium and candida albicans while hospitalized for pneumonia. Comparison of linezolid and daptomycin for the treatment of. Linezolidresistant enterococci are usually resistant to vancomycin and to other antimicrobial agents, though rare cases of clinical enterococcal isolates that are linezolid resistant but vancomycin susceptible have been identified. The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various grampositive bacteria, including meticillinresistant staphylococcus aureus mrsa and vancomycinresistant enterococci vre.
Linezolidresistant enterococci in polish hospitals. Risk factors that might predispose patients to develop linezolid resistant strains include the use of intravascular devices, underdosage, immunosuppression after transplantation, and long courses of linezolid therapy 2040 days. Increasing incidence of linezolid intermediate or resistant, vancomycin resistant enterococcus faecium strains parallels increasing linezolid consumption. Nosocomial spread of enterococcus faecium resistant to. However, the emergence of resistance during linezolid treatment has been reported for clinical strains of enterococcus, which is alarming given the fact that, this leaves the clinician with very few treatment. The genetic relatedness of the isolates, the presence of resistance and virulence genes, and the. The recent publication of the commission for hospital hygiene in germany on enterococcivre recommends screening for linezolid resistant enterococci lre.
Hospital a is an urban, 500bed, adult inpatient, teach. Linezolid is an alternative treatment option for infections with multidrug resistant grampositive bacteria including vancomycin resistant enterococci. Emergence of increasing linezolidresistance in enterococci. Urinary tract infections uti caused by vancomycin resistant enterococcus vre are difficult to manage due to lack of effective oral treatment options. The recent publication of the commission for hospital hygiene in germany on enterococci vre recommends screening for linezolid resistant enterococci. Request pdf gene dosage and linezolid resistance in enterococcus faecium and enterococcus faecalis resistance to linezolid has been associated with a g2576u mutation in domain v of the 23s rrna. We report the first three examples of resistant enterococci two isolates of enterococcus faecium and one enterococcus faecalis isolated in the uk, which were. In march 2014, an outbreak of linezolid resistant enterococcus faecium lrefm was observed at the hematooncology. For the treatment of vancomycin resistant enterococci vre, linezolid, daptomycin, tigecycline, oritavancin, telavancin, quinupristindalfopristin, and teicoplanin are antimicrobials that have been used with success against various vre strains. Linezolid, which has bacteriostatic activity, is approved for the treatment of vancomycin resistant enterococci vre infections. In this retrospective analysis we included all patients with lvre in a universitybased department for hsct in 2014 and 2015.
Although linezolid is bacteriostatic and daptomycin is rapidly bactericidal against vancomycin resistant enterococci in vitro, it is not clear whether they differ in their effect on bacterial clearance in patients with vancomycin resistant enterococci bloodstream infections. Route onset peak duration linezolid linezolid zyvox. Vancomycin resistant enterococci vre are one of the most common nosocomial infections. Enterococcus faecium is part of the human gastrointestinal flora but may act as opportunistic pathogen. Apr 14, 2001 linezolid is a new oxazolidinone antibiotic used to treat infections caused by vancomycin resistant enterococci vre. Wed like to understand how you use our websites in order to improve them. Accuracy of six antimicrobial susceptibility methods for. Different species carrying optra, transfer is likely however the genetic environment of one strain indicate it might be located on the chromossome while the other is on a plasmid. Enterococci resistant to penicillin g by ddt and mic enterococcal species no. All strains contained the g2576u mutation in 23s rrna. Linezolid provides high rates of the clinical cure and microbiological success in complicated infections due to enterococcus spp. This finding may reflect the fact that linezolid is commonly used to treat vre infections.
Validating a screening agar for linezolidresistant. Oct 01, 2004 additional reports of clinical linezolid resistant e. Linezolid has been used to treat such infections extensively. We performed a casecontrol study during a hospital outbreak of linezolidresistant enterococci lre infections, comparing cases of lre infection cases with linezolid sensitive enterococci infections controls. Wgs was 32 performed with short read illumina miseq and long read. Linezolid lnz, an oxazolidinone antibiotic, is an important therapeutic option for infections caused by grampositive bacterial pathogens, especially vancomycin resistant enterococci. Response to emerging infection leading to outbreak of. The purpose of this analysis was to assess the comparative efficacy of linezolid to other vreactive antibiotics in the treatment of uti. Here we report the first german case of necrotizing pancreatitis, peritonitis, and septic shock caused by linezolid resistant enterococcus faecium and enterococcus faecalis. Although instances of linezolid resistance in vre have been reported, resistance has not been encountered among clinical isolates of s aureus. Antimicrobial resistance to linezolid clinical infectious. Between october 2004 and july 2005, 40 patients from whom lrvre organisms were recovered in clinical specimens were characterized. Infections caused by vancomycinresistant enterococcus faecium, nosocomial pneumonia caused by staphylococcusaureusmethicillinsusceptible.
Lzd resistant lr genetic features include mutations in 23s rrnaribosomal proteins, a plasmidborne 23s rrna methyltransferase gene cfr, and ribosomal protection genes optra and poxta. We report the first three examples of resistant enterococci two isolates of enterococcus faecium and one enterococcus faecalis isolated in the uk, which were obtained from patients who had received linezolid. Although none of them had received linezolid or chloramphenicol, all had antecedents of recent quinolone consumption. Novel linezolid resistance plasmids in enterococcus from food animals in the usa article pdf available in journal of antimicrobial chemotherapy 7312 october 2018 with 7 reads. Daptomycin and linezolid are primary treatment options although definitive clinical data to assess comparative therapeutic effectiveness are. What are the treatment options for vancomycinresistant. Six different types of vancomycin resistance are shown by enterococcus.
Pdf colonisation with vancomycin and linezolidresistant. Linezolid, the first oxazolidinone antibacterial agent to be developed for clinical use, was licensed in the uk in early 2001. Prevalence of vancomycin resistant enterococci has increased in germany. In early clinical trials, emergence of resistance occurred rarely.
Environmental persistence, high colonization capability and diverse intrinsic and acquired resistance mechanisms make it especially successful in nosocomial highrisk settings. The first case of lre in poland occurred in july 2003, shortly after the introduction of linezolid for treatment in our country in february 2002 29. Linezolid for treatment of vancomycinresistant enterococcal. Because of the increase in multidrug resistant strains of grampositive bacteria, the development of new and novelacting antimicrobial agents is at the forefront of pharmaceutical research.
1135 1164 7 730 97 844 467 197 485 811 1242 1557 36 353 400 1322 13 923 1236 1019 685 623 201 804 1063 184 1317 1348 984 1530 1186 1200 988 505 576 410 971 255 112 647 1216 1 134 876 1060